Key facts
- This page summarizes Scott Shuda's Form 4 filing for InfuSystem Holdings, Inc (INFU).
- 2 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 20 May 2025, 18:54.
Scott Shuda - 16 May 2025 Form 4 Insider Report for InfuSystem Holdings, Inc (INFU)
- Reporting relationship
- Director
- Issuer ticker
- INFU
- Reported as of
- 16 May 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 20 May 2025, 18:54:23 UTC
- Prior SEC filing
- 25 Apr 2025
- Next SEC filing
- 24 Jun 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Kevin R. Whitman, Attorney-in-Fact for Scott Shuda
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Scott Shuda filed Form 4 for InfuSystem Holdings, Inc (INFU) on 20 May 2025.
Change
- Previous filing in this sequence was filed on 25 Apr 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001486636
Primary reporting owner
Shuda Scott
- Relationship
- Director
- Address
- C/O INFUSYSTEM HOLDINGS, INC., 3851 WEST HAMLIN ROAD, ROCHESTER HILLS
- Signature
- /s/ Kevin R. Whitman, Attorney-in-Fact for Scott Shuda
- Signature date
- 20 May 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
INFU
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 101,994
- Date
- 16 May 2025
- Ownership
- Direct
INFU
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 298,383
- Date
- 16 May 2025
- Ownership
- Footnote 1
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
INFU
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +39,588
- Change %
- Price
- $0.000000
- Shares after
- 39,588
- Date
- 16 May 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 39,588
- Exercise price
- $6.00
- Footnotes
- F2
INFU
transaction
Derivative
Stock Options (right to buy)
Award
- Transaction value
- $0
- Shares
- +11,876
- Change %
- Price
- $0.000000
- Shares after
- 11,876
- Date
- 16 May 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 11,876
- Exercise price
- $6.00
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Mr. Shuda serves as Managing Director of (i) TSV Investment Partners, LLC, which is the sole general partner of Meridian OHC Partners, LP ("Meridian") and (ii) BlueLine Partners, LLC, which is the sole general partner of BlueLine Capital Partners II ("BlueLIne"). Accordingly, Mr. Shuda holds voting and dispositive power over the Common Stock held by Meridian and BlueLine. Mr. Shuda disclaims beneficial ownership for purposes of Rule 13d-3 with respect to the Common Stock held by Meridian and BlueLine
Footnote F2
The option, representing the right to purchase 39,588 shares of InfuSystem Holdings, Inc. common stock, vests on May 16, 2026.
Footnote F3
The option, representing the right to purchase 11,876 shares of InfuSystem Holdings, Inc. common stock, vests on May 16, 2026.